Show channels:
All channels
Bladder cancer
Brain and spinal
Breast cancer
Cervical
Colon & rectal
Dermatological
General Information
Gynecological
Head and Neck
Kidney/adrenal
Liver
Lung
Lymphoma
Multiple Myeloma
Myelodysplastic syndromes
Myeloproliferative disorders
Pancreas
Pediatric
Prostate
Sarcoma
Stomach
Testicular
Thyroid
Upper aerodigestive
Found 15790 articles
DCLK1 might be a therapeutic target of osthole against cervical cancer.
Osthole significantly inhibits survival of cervical cancer cells.
»
10/08/21
Predictive models of response to neoadjuvant chemotherapy in muscle-invasive bladder cancer using nuclear morphology and tissue architecture.
Computational approaches applied to routine pathology specimens should be considered.
»
01/30/21
Co-expression of YAP and TAZ associates with chromosomal instability in human cholangiocarcinoma
Presence of CIN genes in about 25% of iCCA statistically associated with worse prognosis.
»
10/06/21
Minimally important differences for the EORTC QLQ-C30 in prostate cancer clinical trials
Within-group MIDs ranged from 4 to 14 points for improvement.
»
10/07/21
Modelling hypersensitivity to trastuzumab defines biomarkers of response in HER2 positive breast cancer
Different cellular models also showed distinct response to other anti-HER2 drugs.
»
10/07/21
Results of the observational prospective RealFLOT study
Disease-free survival (DFS) and OS significantly longer in case of pCR.
»
10/08/21
Cancer microcell initiation and determination
Cancer microcells viable and capable of resisting stress induced by anticancer drugs.
»
10/08/21
Novel chemotherapeutic agent FX-9 activates NF-κB signaling and induces G1 phase arrest by activating CDKN1A in a human prostate cancer cell line
FX-9 induced G1-phase arrest of PC-3 cells .
»
10/08/21
Whole genome copy number analyses reveal a highly aberrant genome in TP53 mutant lung adenocarcinoma tumors
Large number of genes displayed correlation between copy number and expression level.
»
10/09/21
Investigating the potential of proton therapy for hypoxia-targeted dose escalation in non-small cell lung cancer
Use of protons could also simultaneously reduce mean doses to heart.
»
10/11/21
< Prev
Next >